Loading…

Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis

Background To propose an ultrasound-based parameter for the diagnosis of muscle mass loss (MML) in cirrhosis. Methods This is an IRB-approved cross-sectional study (October 2013 to January 2017) with written informed consent including 357 subjects—234 cirrhosis and 123 controls. MML was diagnosed us...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology 2018-05, Vol.53 (5), p.652-659
Main Authors: Kobayashi, Kazufumi, Maruyama, Hitoshi, Kiyono, Soichiro, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Chiba, Tetsuhiro, Kato, Naoya, Yamaguchi, Tadashi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background To propose an ultrasound-based parameter for the diagnosis of muscle mass loss (MML) in cirrhosis. Methods This is an IRB-approved cross-sectional study (October 2013 to January 2017) with written informed consent including 357 subjects—234 cirrhosis and 123 controls. MML was diagnosed using the skeletal muscle index at the L3 level (L3-SMI) on computed tomography (CT). Transcutaneous ultrasound was used to demonstrate a cross section of the right iliopsoas muscle, and the iliopsoas muscle index (IP index) was defined by the iliopsoas muscle area/height 2 (mm 2 /m 2 ). Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic ability of IP index for MML. Results The iliopsoas muscle was detected in all subjects. The IP index was lower in cirrhosis than in controls: males (211.2 ± 73.8 vs. 295.5 ± 139.4, P  
ISSN:0944-1174
1435-5922
DOI:10.1007/s00535-017-1378-2